Search
for
Sort by
Research 181–210 of 1000+
- Zinc deficiency associated with hypothyroidism: An overlooked cause of severe alopecia
- A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata
- Interest of High-Dose Pulse Corticosteroid Therapy Combined with Methotrexate for Severe Alopecia Areata: A Retrospective Case Series
- A trial of 1% minoxidil used topically for severe alopecia areata
- Combined oral pulse and topical corticosteroid therapy for severe alopecia areata in children: a long-term follow-up study
- A trial of 1% minoxidil used topically for severe alopecia areata.
- Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials
- Low-Dose IL-2 for Treating Moderate to Severe Alopecia Areata: A 52-Week Multicenter Prospective Placebo-Controlled Study Assessing its Impact on T Regulatory Cell and NK Cell Populations
- Effectiveness and safety of baricitinib in patients with severe alopecia areata: a 36-week multicenter real-world experience
- High-dose steroid pulse therapy for the treatment of severe alopecia areata.
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
- Sequential high‐ and low‐dose systemic corticosteroid therapy for severe childhood alopecia areata
- A systematic review on the treatment of pediatric severe alopecia areata by topical immunotherapy or Anthralin (contact sensitization) or low‐level light/laser therapy (LLLT): focus on efficacy, safety, treatment duration, recurrence, and follow‐up based on clinical studies
- Role of Hair Prostheses (Wigs) in Patients with Severe Alopecia Areata
- High‐dose pulsed corticosteroid therapy combined with methotrexate for severe alopecia areata of childhood
- Higher concentrations of dithranol appear to induce hair growth even in severe alopecia areata
- Safety and Efficacy of Adalimumab for the Treatment of Severe Alopecia Areata: Case Series of Three Patients
- Hyperpigmentation, severe alopecia, and six days of instability in a case of severe methotrexate hypersensitivity reaction
- Efficacy of intradermal minoxidil 5% injections for treatment of patchy non-severe alopecia areata
- Excimer lamp as an effective alternative treatment for severe alopecia areata
- Real-world assessment of ritlecitinib in patients with severe alopecia areata: a 24-week multicentre retrospective study
- FDA approval of Deuruxolitinib: A New Treatment Option for Severe Alopecia Areata
- 34007 Efficacy and safety of baricitinib in adult patients with severe alopecia areata with or without an atopic background from 2 randomized, placebo-controlled, phase 3 trials
- Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for moderate to severe alopecia areata: a dose-ranging meta-analysis of 1,372 randomized patients
- Predominance of CD27-PD-1- Effector Memory T Cells Re-Expressing CD45RA Characterizes Treatment-Resistant Severe Alopecia Areata
- Short-term malignancy risk of JAK inhibitors in severe alopecia areata: a multicenter cohort study
- 51840 Efficacy of the Oral JAK1/JAK2 Inhibitor Deuruxolitinib in Adult Patients with Moderate to Severe Alopecia Areata: Pooled Results from the Multinational Double-Blind, Placebo-Controlled THRIVE-AA1 and THRIVE-AA2 Phase 3 Trials
- 43018 Safety Analysis of Baricitinib in Adult Patients with Severe Alopecia Areata From 2 Randomized Clinical Trials over a Median of 1.6 years and up to 3.6 Years of Exposure
- Microneedling combined with compound betamethasone in treatment of severe alopecia areata: A case report
- Oral Tofacitinib for the Management of Moderate to Severe Alopecia Areata in Children and Adolescents: A Retrospective Study of 36 Patients